Venus Concept Secures 510(k) Approval for Venue NOVA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
FDA Clearance: Venus Concept has received 510(k) clearance from the U.S. FDA to market the Venus NOVA, a next-generation multi-application platform for non-invasive treatments.
Technology Integration: The Venus NOVA combines Adaptive Electrical Muscle Stimulation, Multi-Polar Radio Frequency with Pulsed Electromagnetic Fields, and Advanced VariPulse technology for comprehensive body contouring and skin treatments.
Treatment Benefits: The platform is designed to enhance muscle conditioning, skin treatments, and reduce wrinkles and cellulite.
Market Impact: This innovative technology aims to redefine non-invasive aesthetic treatments in the beauty and wellness industry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
